Trade AbbVie ^ABBV

AbbVie's Temab-A Earns FDA Breakthrough Therapy Designations In CRC, NSCLC;Stock Up

AbbVie's Telisotuzumab Adizutecan Secures Dual FDA Breakthrough Therapy Designations

AbbVie (NYSE:ABBV) Hits New 12-Month High on Analyst Upgrade - Stock Observer

Genmab (CPSE:GMAB) Posts Two Strong Trial Readouts, Is The Valuation Now Too Hard To Ignore?

AbbVie (ABBV) Cut Frontline DLBCL Progression Or Death Risk By 51%

AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?

AbbVie Stocks Edge Higher as Lymphoma Trial Cuts Progression Risk 51%

Forget Bonds: How Retirees Collect $6,650 a Month From Dividends Alone

AbbVie Inc. $ABBV Stock Sold by Hall Laurie J Trustee - Daily Political

Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss

Abbvie-Genmab Epkinly data signal first-line filing for DLBCL

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms

Scotiabank Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

$100,000 in 5 Dividend Kings Will Generate Close to $4,000 Each Year Safely

AbbVie Rewarded Patient Investors but Punished Those Who Bought on Good News

AbbVie (NYSE:ABBV) Releases Q3 2026 Earnings Guidance

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug | Morningstar

Genmab and AbbVie's Epcoritamab Treatment Significantly Reduces Blood Cancer Progression Risk, ETPharma

AbbVie Inc. (ABBV) Stock: Phase 3 Lymphoma Trial Cuts Progression Risk 51%

AbbVie (NYSE:ABBV) Stock Price Up 1.2% - Still a Buy?

Genmab stock surges 11% on positive cancer drug trial data

Park National Corp OH Sells 6,771 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Lowered by Eastern Bank

AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

AbbVie (NYSE:ABBV) Stock Jumps 1.2% - Still a Buy? - Daily Political

AbbVie Inc. $ABBV Stock Position Lessened by MassMutual Private Wealth & Trust FSB

Best Pharmaceutical Stocks To Add to Your Watchlist - October 4th - Stock Observer

Is AbbVie (ABBV) Still Undervalued On FDA Approval And Fresh Pipeline Data?

AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?

Pharmaceutical Stocks To Watch Now - October 3rd - Zolmax

5 High-Yield Dividend Stocks to Buy for October Income with Cash Flow to Spare

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Biotech Stocks To Watch Now - October 2nd - Daily Political

Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories

AbbVie (NYSE:ABBV) Stock Jumps 1.3% - Here's What Happened

How Much Does a 58-Year-Old Need Invested to Replace a $160,000 Salary With Dividends?

CX Institutional Cuts Stock Position in AbbVie Inc. $ABBV - Daily Political

Biotech Stocks To Watch Now - October 2nd - Zolmax

Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease

RINVOQ Drives Continued Skin Repigmentation Through Week 76 In AbbVie Studies

HRSA discloses manufacturers approved for revised 340B rebate pilot

5 Solid Dividend Stocks to Buy Now

AbbVie to Host Third-Quarter 2026 Earnings Conference Call | Morningstar

5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)

RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)

What Does AbbVie (ABBV) Need To Prove After Its Eczema Drug And AI Update?

AbbVie To Present New Dermatology Data At 2026 EADV Congress

Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson

AbbVie Inc. (ABBV) Stock: Rebounds as Zumilokibart Shows Strong Skin and Itch Improvement Results

BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength

AbbVie Reports Positive Phase 2 Results For Zumilokibart In Atopic Dermatitis

AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study

AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026 | Morningstar

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress | Morningstar

AbbVie (NYSE:ABBV) Shares Down 1% - Should You Sell?

AbbVie Stock Drops Although Juvmo Wins Parkinson's Approval

AbbVie Partners With Valkai To Advance AI-powered Clinical Research

Allergan Aesthetics receives Health Canada authorization for Boey® (trenibotulinumtoxinE), the first and only rapid-onset, short-duration neurotoxin for frown lines

AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts

FDA Nod For JUVMO Parkinson's Drug Could Be A Game Changer For AbbVie (ABBV)

Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's?

Best Pharmaceutical Stocks To Follow Now - September 26th - Daily Political

Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial

Should FDA Approval Require Action From AbbVie (ABBV) Investors?

Johnson & Johnson's Next Growth Engine Is Taking Shape

AbbVie Wins FDA Approval For JUVMO In Parkinson's Disease

Kodiak soars on double phase III win in wet AMD

AbbVie Won FDA Approval for Parkinson's Pill Juvmo. Here's Why Management Already Expects a Slow Start

AbbVie lands FDA approval for next-generation Parkinson's drug, Juvmo

AbbVie (ABBV) Stock: FDA Greenlights Innovative Parkinson's Treatment Juvmo - Blockonomi

AbbVie Gets FDA OK of Juvmo for Parkinson's Disease | Morningstar

AbbVie Announces FDA Approval Of JUVMO For Parkinson's Disease

US FDA approves AbbVie's drug for Parkinson's disease

Abbvie's Juvmo FDA approval brings new Parkinson's option | BioWorld

International practice patterns and beliefs concerning intravenous methylprednisolone and low-dose aspirin in giant cell arteritis

AI Could Give AbbVie (ABBV) a New Route to Long-Term Pipeline Growth

How to Build $7,250 a Month in Dividend Income Without Owning a Single Yield Trap

What Does AbbVie (ABBV) Need To Prove With Its Latest Pipeline Moves?

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study

AbbVie (ABBV) Wins A New Lymphoma Nod, Is The Stock Still Cheap?

ABBV vs. JNJ: One of These Dividend Aristocrats Will Crush the Other Over the Next Decade

Weekly Buzz: MESO, LLY, ANIP Win FDA Nod; KALA, HCTI Sign LOI; IMVT Halts Lupus Study

ADARx Pharmaceuticals raises $446 million in upsized IPO

ADARx prices upsized Nasdaq IPO at top

RNAi drug specialist ADARx raises $446M IPO

AbbVie's EPKINLY Receives Health Canada Approval For Follicular Lymphoma

Rep. Pete Sessions Sells Off Shares of Apple Inc. (NASDAQ:AAPL)

EPKINLY® receives Health Canada Approval for Adults with Follicular Lymphoma | INN

Ulcerative Colitis Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire

QRG Capital Management Inc. Increases Stake in AbbVie Inc. $ABBV

Envestnet Portfolio Solutions Inc. Raises Stock Position in AbbVie Inc. $ABBV

PepsiCo Stock Forecast 2026 and 2030: Is PEP a Good Stock to Buy?

Samsung Electronics Stock Price Forecast 2026–2027: Can Record Q3 Profit Extend the AI Rally?

GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?

AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

EUR/USD Near 17-Month Lows as French Fiscal Concerns Fuel Dollar Strength

Gold Price Today: Bullion Near $4,100 as Fed Hike Risks Persist

Samsung Q3 Operating Profit Jumps Nearly Ninefold to Record 107.4 Trillion Won as Memory Shortage Deepens

Oil Price Today: Crude Rebounds as Middle East Attacks Raise Supply Fears

TSMC Q3 Revenue Jumps 51%, Beats Estimates as AI Chip Demand Supports Record Sales

Bitcoin Price Today Falls Below $83,000 as $696 Million Liquidation Wave Hits Crypto Market

PepsiCo Earnings Preview: Can North America Recovery Lift PEP Stock?

SpaceX Seeks $40 Billion to Buy Nvidia Chips as AI Debt Concerns Intensify